FDA Flu Vaccine Immunization Program
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q00257
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a solicitation for its annual Flu Vaccine Immunization Program. This procurement initiative is designed to support the FDA’s Occupational Health Services (OHS) in delivering a comprehensive, work-related medical program that includes immunizations for its workforce. The primary objective is to ensure the timely purchase and delivery of seasonal influenza vaccine doses, thereby promoting employee health and aligning with CDC recommendations for influenza prevention.
The scope of this contract encompasses the procurement and delivery of a total of 2,200 units of FDA-approved seasonal influenza vaccines for the 2026–2027 season. The vaccines must be supplied in single-dose pre-filled syringes and adhere strictly to CDC cold chain requirements for shipping, storage, and handling. Packaging for each unit must clearly display the manufacturer, National Drug Code (NDC) number, lot number, and expiration date, ensuring traceability and compliance.
The order is divided as follows:
- 2,000 units formulated for adults under 65 years of age
- 200 units formulated for adults 65 years of age and older
It is important to note that the contract is limited to the procurement and delivery of the vaccines. The following services are explicitly excluded: on-site storage or refrigeration, inventory or tracking systems, clinical staffing or administrative services, logistical planning or coordination, and recordkeeping or documentation support. Contractors should be aware that their responsibilities end upon successful delivery to the designated FDA Occupational Health Units at the White Oak Campus in Silver Spring, Maryland, and the Jefferson Laboratories Campus in Jefferson, Arkansas.
The procurement is classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing), with Product Service Code 6505. There are no set-aside requirements for this solicitation, making it open to all qualified vendors. The contracting entity is the FDA Office of Acquisition and Grant Services, a federal office within the Food and Drug Administration. The primary point of contact for this opportunity is Amanda Edger, who can be reached at [email protected].
The solicitation was posted on January 7, 2026, and responses are due by July 20, 2026. Interested parties can access further details and attachments via the official SAM.gov opportunity page at https://sam.gov/opp/c409bc12530d4b0a9f08ee978355064b/view.
Contractors considering this opportunity should ensure their products meet all FDA and CDC requirements and be prepared to deliver the specified quantities to the designated locations. The scope is strictly limited to vaccine procurement and delivery, with no ancillary services required. This solicitation represents a straightforward supply contract, ideal for manufacturers and distributors specializing in pharmaceutical preparations, particularly those with experience in large-scale vaccine fulfillment for federal agencies.